Literature DB >> 42476

Effect of ergocristine on prolactin secretion in the male rat with pituitaries grafted beneath the kidney capsule.

S H Shin.   

Abstract

Male rats in which three pituitaries were grafted beneath the kidney capsule showed approximately a fourfold increase in circulating plasma prolactin concentration. The elevated plasma prolactin concentration did not remain at a constant level but fluctuated with time. The elevated prolactin concentration declined immediately after a single bolus injection of ergocristine (30 micrograms/kg). The slope of the prolactin decay curve, determined by sequential blood sampling, was parallel to a theoretical slope having a 7-min half-life. This result indicates that ergocristine blocked prolactin secretion immediately and completely as the decay curve (T 1/2 = 6.5 min, confidence interval 4.5--11.3) resulting from the administration of ergocristine is the same as the endogenous prolactin decay curve (T 1/2 = 7 min).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 42476     DOI: 10.1139/y79-195

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  3 in total

1.  Daily water and electrolyte balance in chronically hyperprolactinaemic rats.

Authors:  S Kaufman; B J Mackay; J Z Scott
Journal:  J Physiol       Date:  1981-12       Impact factor: 5.182

2.  Extensive ultrastructural changes in rat mammotrophs following administration of the dopamine agonist ergocristine-reflecting inhibition of prolactin release.

Authors:  C W Reifel; S H Shin; R A Leather
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

3.  Effects of Continuously Feeding Diets Containing Cereal Ergot Alkaloids on Nutrient Digestibility, Alkaloid Recovery in Feces, and Performance Traits of Ram Lambs.

Authors:  Stephanie Coufal-Majewski; Kim Stanford; Tim McAllister; Yuxi Wang; Barry Blakley; John McKinnon; Mary Lou Swift; Alexandre V Chaves
Journal:  Toxins (Basel)       Date:  2017-12-19       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.